Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EMT Inhibitor-2, targeting both CYP3A4 testosteron and CYP2C9, exhibits inhibitory effects with IC50 values of 49.72 and 5.54 μM, respectively. Furthermore, it effectively impedes the epithelial-mesenchymal transition (EMT) process, induced by immunocyte-released agents like IL-1β and TGF-β.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約8-10 週間 | ¥ 321,500 |
50 mg | 約8-10 週間 | ¥ 418,000 |
100 mg | 約8-10 週間 | ¥ 647,500 |
説明 | EMT Inhibitor-2, targeting both CYP3A4 testosteron and CYP2C9, exhibits inhibitory effects with IC50 values of 49.72 and 5.54 μM, respectively. Furthermore, it effectively impedes the epithelial-mesenchymal transition (EMT) process, induced by immunocyte-released agents like IL-1β and TGF-β. |
分子量 | 470.47 |
分子式 | C24H26N2O8 |
CAS No. | 2232228-60-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EMT inhibitor-2 2232228-60-1 Others EMT inhibitor 2 EMT inhibitor2 Inhibitor inhibitor inhibit